Tianshui Zhongxing Bio-technology Co.,Ltd. (SHE:002772)
7.88
-0.01 (-0.13%)
Oct 28, 2026, 3:04 PM CST
SHE:002772 Revenue
Tianshui Zhongxing Bio-technology had revenue of 519.30M CNY in the quarter ending September 30, 2026, a decrease of -8.50%. This brings the company's total for the last twelve months to 2.23B, up 11.71% year-over-year. In the year 2025, Tianshui Zhongxing Bio-technology had annual revenue of 2.10B with 8.43% growth. That makes Tianshui Zhongxing Bio-technology the 13,765th largest company in the world by revenue and 2,435th in China.
Revenue (ttm)
2.23B
Revenue Growth
+11.71%
P/S Ratio
1.33
Revenue / Employee
242.64K
Employees
9,181
Market Cap
2.95B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:002772 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.10B | 163.14M | 8.43% |
| Dec 31, 2024 | 1.94B | 4.15M | 0.21% |
| Dec 31, 2023 | 1.93B | -39.20M | -1.99% |
| Jan 1, 2023 | 1.97B | 414.13M | 26.61% |
| Dec 31, 2021 | 1.56B | 72.97M | 4.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.